Literature DB >> 2020303

Post-transplantation lymphoproliferative disorder and OKT3.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2020303     DOI： 10.1056/NEJM199105163242012

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

Review 1.  Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.

Authors:  M I Wilde; K L Goa
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.